8/29/2014 - 11:41 AM EST - iCo Therapeutics : reported financial results for the six months ended June 30, 2014. Co incurred total comprehensive loss of $1,617,040 (loss per share of $0.02), compared to a total comprehensive loss of $2,886,831 (loss per share of $0.05) for the six months ended June 30, 2013, representing a decrease of $1,269,791 in comprehensive loss. iCo Therapeutics
shares V.ICO are trading unchanged at $0.07.